Genmark Diagnostics

Genmark Diagnostics Current Assets

Delisted

The Current Assets of Genmark Diagnostics (GNMK) as of Oct 10, 2026 is 172.96 M USD. In the previous year, Current Assets was 83.40 M USD — a change of 107.40% (higher).

Current Assets

172.96 MUSD

YoY

107.40%

Last updated:

Current Assets of Genmark Diagnostics is 2020 172.96 M USD. Current Assets of Genmark Diagnostics was 2019 83.40 M USD. It decreases by 107.40% higher compared to the previous year.

The Genmark Diagnostics Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2013
111.14 M USD
Jan 1, 2014
7.60 M USD
Jan 1, 2015
55.96 M USD
Jan 1, 2016
58.45 M USD
Jan 1, 2017
95.41 M USD
Jan 1, 2018
68.43 M USD
Jan 1, 2019
83.40 M USD
Jan 1, 2020
172.96 M USD
The Genmark Diagnostics Current Assets history
YEARCurrent AssetsYoY
172.96 MUSD+107.40%
83.40 MUSD+21.87%
68.43 MUSD-28.28%
95.41 MUSD+63.23%
58.45 MUSD+4.45%
55.96 MUSD+636.18%
7.60 MUSD-93.16%
111.14 MUSD+91.59%
58.01 MUSD+71.08%
33.91 MUSD+1,524.19%
2.09 MUSD+57.10%
1.33 MUSD-55.91%
3.01 MUSD—
Access this data via the Eulerpool API
Get Free API Key

Genmark Diagnostics Stock analysis

What does Genmark Diagnostics do? The company Genmark Diagnostics was founded in 1999 in California, USA. Its goal is to develop and produce diagnostic and testing solutions for the medical and biotechnology industries, with a focus on microfluidic technology. The company offers comprehensive services from the development of diagnostic and testing solutions to the production of devices and systems. Its main business areas are molecular diagnostics, laboratory test automation, and genomics. Genmark Diagnostics provides a variety of test solutions for diseases in the field of molecular diagnostics, as well as automation platforms for laboratory testing and products for genomic analysis. The company's products, such as the ePlex® system, aim to improve the accuracy and speed of medical diagnostics. Genmark Diagnostics is headquartered in Carlsbad, California, USA and has international branches. Its mission is to enhance the accuracy and speed of medical diagnostics worldwide through innovative devices and systems. Genmark Diagnostics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmark Diagnostics stock

Current Assets of Genmark Diagnostics is 172.96 M USD in 2020.

Current Assets of Genmark Diagnostics changed from 83.40 M USD to 172.96 M USD, representing a 107.40% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Genmark Diagnostics since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Genmark Diagnostics historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Genmark Diagnostics

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Genmark Diagnostics